Van Leuven F - Search Results

1

Alzheimer's disease: old problem, new views from transgenic and viral models.

Jaworski T, Dewachter I, Seymour CM, Borghgraef P, Devijver H, Kügler S, Van Leuven F. Jaworski T, et al. Among authors: van leuven f. Biochim Biophys Acta. 2010 Oct;1802(10):808-18. doi: 10.1016/j.bbadis.2010.03.005. Epub 2010 Mar 21. Biochim Biophys Acta. 2010. PMID: 20332023 Free article. Review.

2

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.

Terwel D, Dewachter I, Van Leuven F. Terwel D, et al. Among authors: van leuven f. Neuromolecular Med. 2002;2(2):151-65. doi: 10.1385/NMM:2:2:151. Neuromolecular Med. 2002. PMID: 12428809 Review.

3

Secretases as targets for the treatment of Alzheimer's disease: the prospects.

Dewachter I, Van Leuven F. Dewachter I, et al. Among authors: van leuven f. Lancet Neurol. 2002 Nov;1(7):409-16. doi: 10.1016/s1474-4422(02)00188-6. Lancet Neurol. 2002. PMID: 12849363 Review.

4

Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models.

Boom A, Pochet R, Authelet M, Pradier L, Borghgraef P, Van Leuven F, Heizmann CW, Brion JP. Boom A, et al. Among authors: van leuven f. Biochim Biophys Acta. 2004 Dec 6;1742(1-3):161-8. doi: 10.1016/j.bbamcr.2004.09.011. Biochim Biophys Acta. 2004. PMID: 15590066 Free article.

5

Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects.

van Dooren T, Dewachter I, Borghgraef P, van Leuven F. van Dooren T, et al. Among authors: van leuven f. Subcell Biochem. 2005;38:45-63. doi: 10.1007/0-387-23226-5_2. Subcell Biochem. 2005. PMID: 15709472 Review.

6

Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.

Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F. Terwel D, et al. Among authors: van leuven f. Am J Pathol. 2008 Mar;172(3):786-98. doi: 10.2353/ajpath.2008.070904. Epub 2008 Feb 7. Am J Pathol. 2008. PMID: 18258852 Free PMC article.

7

Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare.

Maurin H, Seymour CM, Lechat B, Borghgraef P, Devijver H, Jaworski T, Schmidt MV, Kuegler S, Van Leuven F. Maurin H, et al. Among authors: van leuven f. PLoS One. 2013 May 21;8(5):e63589. doi: 10.1371/journal.pone.0063589. Print 2013. PLoS One. 2013. PMID: 23704923 Free PMC article.

8

Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.

Maurin H, Chong SA, Kraev I, Davies H, Kremer A, Seymour CM, Lechat B, Jaworski T, Borghgraef P, Devijver H, Callewaert G, Stewart MG, Van Leuven F. Maurin H, et al. Among authors: van leuven f. PLoS One. 2014 Feb 3;9(2):e87605. doi: 10.1371/journal.pone.0087605. eCollection 2014. PLoS One. 2014. PMID: 24498342 Free PMC article.

9

Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.

Maurin H, Lechat B, Borghgraef P, Devijver H, Jaworski T, Van Leuven F. Maurin H, et al. Among authors: van leuven f. Eur J Neurosci. 2014 Jul;40(2):2442-53. doi: 10.1111/ejn.12595. Epub 2014 Apr 23. Eur J Neurosci. 2014. PMID: 24754737

10

Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.

Muyllaert D, Terwel D, Borghgraef P, Devijver H, Dewachter I, Van Leuven F. Muyllaert D, et al. Among authors: van leuven f. Rev Neurol (Paris). 2006 Oct;162(10):903-7. doi: 10.1016/s0035-3787(06)75098-6. Rev Neurol (Paris). 2006. PMID: 17028556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters